Predicting the short term direct medical costs incurred by patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 26, Issue 5, 1999, Pages 1068-1075

  Clarke, Ann E ^a,b   Levinton, Carey ^b   Joseph, Lawrence ^a   Penrod, John ^a   Zowall, Hanna ^b   Sibley, John T ^c   Grover, Steven A ^a   Esdaile, John M ^d  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Disability; Health care costs; Predictors; Rheumatoid arthritis

Indexed keywords

METHOTREXATE;

AGE; ARTICLE; DISABILITY; DISEASE DURATION; EDUCATION; EMPLOYMENT; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; PAIN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; STATISTICAL MODEL; WELLBEING;

EID: 0032952435     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Badley EM. The economic burden of musculoskeletal disorders in Canada is similar to that for cancer, and may be higher [editorial]. J Rheumatol 1995;22:204-6.
2. Badley EM, Rasooly I, Webster GK. Relative importance of musculoskeletal disorders as a cause of chronic health problems, disability, and health care utilization: findings from the 1990 Ontario Health Survey. J Rheumatol 1994;21:505-14.
3. Yelin E, Callahan LF, for the National Arthritis Data Work Group. The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum 1995;38:1351-62.
4. Felts W, Yelin E. The economic impact of the rheumatic diseases in the United States. J Rheumatol 1989;16:867-84.
5. Clarke AE, Zowall H, Levinton C, et al. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a twelve year study. J Rheumatol 1997;24:1051-60.
6. Lubeck DP, Spitz PW, Fries JF, Wolfe F, Mitchell DM, Roth SH. A multicenter study of annual health service utilization and costs in rheumatoid arthritis. Arthritis Rheum 1986;29:488-93.
7. Liang MH, Larson M, Thompson M, et al. Costs and outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1984;27:522-9.
8. Hawley DJ, Wolfe F. Anxiety and depression in patients with rheumatoid arthritis: a prospective study of 400 patients. J Rheumatol 1988;15:932-41.
9. Katz PP, Yelin EH. Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis. J Rheumatol 1993;20:790-6.
10. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:127-34.
11. Clarke AE, Esdaile JM, Bloch DA, Lacaille D, Danoff DS, Fries JF. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum 1993;36:1548-59.
12. Gironimi G, Clarke AE, Hamilton VH, et al. Why health care costs more in the US: comparing health care expenditures between systemic lupus erythematosus patients in Stanford and Montreal. Arthritis Rheum 1996;39:979-87.
13. Luce BR, Elixhauser A. Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess Health Care 1990;6:57-75.
14. Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Q 1982;60:429-62.
15. Baladi JF. A guidance document for the costing process. Ottawa, Ontario: Canadian Coordinating Office for Health Technology Assessment; 1996.
16. Hospital Statistics: Preliminary Annual Report. 1992-1993. Ottawa: Statistics Canada; 1994; Cat. No.:83-241.
17. Residential Care Facilities - Aged. 1992-1993. Ottawa: Statistics Canada; 1994: Cat. No.; 83-237.
18. Kass R, Raftery A. Bayes factors. JAm Stat Assoc 1995;90:773-95.
19. Aitchison J, Brown JAC. The lognormal distribution: with special reference to its use in economics. Cambridge: Cambridge University Press; 1957.
20. Singh G, Terry R, Ramey D, Wolfe F, Fries J. Long-term medical costs and outcomes are significantly associated with early changes in disability in rheumatoid arthritis [abstract]. Arthritis Rheum 1996;39 Suppl:S318.
21. Clarke AE, Bloch DA, Danoff DS, Esdaile JM. Decreasing costs and improving outcomes in SLE using regression trees to develop health policy. J Rheumatol 1994;21:2246-53.
22. Smedstad LM, Moum T, Guillemin F, et al. Correlates of functional disability in early rheumatoid arthritis: a cross-sectional study of 706 patients in four European countries. Br J Rheumatol 1996;35:746-51.
23. Suarez-Almazor ME, Soskolne CL, Saunders D, Russell AS. Outcome in rheumatoid arthritis. A 1985 inception cohort study. J Rheumatol 1994;21:1438-46.
24. Sherrer YS, Bloch DA, Mitchell DM, Young DY, Fries JF. The development of disability in rheumatoid arthritis. Arthritis Rheum 1986;29:494-500.
25. Mitchell DM, Spetz PW, Young DY, Bloch DA, McShane DJ, Fries JF. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 1986;29:706-14.